GSK Scientists Knew About Zantac ' s Cancer Risks For Forty Years

GSK Scientists Knew About Zantac's Cancer Risks For Forty Years Three years after the Food & Drug Administration (FDA) pulled GSK Plc's heartburn drug Zantac off the market due to suspected links to cancer, and just two weeks before the trial begins of a man who alleges he developed bladder cancer…#fda #gskplc #gsk #zantac #glaxo #ndma #931ng #eveliogrillo
Source: Reuters: Health - Category: Consumer Health News Source Type: news